Last reviewed · How we verify

NCT05920486

High-Intensity Laser Therapy in Patients With Sacroiliitis

Status unknown NA Last updated 27 June 2023
What this trial tests

NA trial testing High-Intensity Laser Therapy (HILT) in Sacroiliac Arthritis in 64 participants. Status unknown.

Timeline
22 June 2023
Primary endpoint
22 March 2024
1 April 2024

Quick facts

Lead sponsorAhram Canadian University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment64
Start date22 June 2023
Primary completion22 March 2024
Estimated completion1 April 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ahram Canadian University

Who can join

Adults 40 to 60, any sex, with Sacroiliac Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the effectiveness of High-Intensity Laser Therapy (HILT) in reducing pain and improving function in patients with sacroiliitis, aged 40-60 years.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of High-Intensity Laser Therapy (HILT)

Trials testing the same drug.

Other Ahram Canadian University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05920486.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing